Maintenance of cognitive performance and mood for individuals with Alzheimer’s disease following consumption of a nutraceutical formulation: a one-year, open-label study

Manuscript Number: 

15-1098R1

Author(s): 
Cynthia Bechtel, David Larsen, Christopher Morrell, Robert Page, Ruth Remington, Annmarie Samar, Thomas B. Shea

Disclosures

Cynthia Bechtel

  • Nothing to Disclose

David Larsen

  • Nothing to Disclose

Christopher Morrell

  • Nothing to Disclose

Robert Page

  • Nothing to Disclose

Ruth Remington

  • Nothing to Disclose

Annmarie Samar

  • Nothing to Disclose

Thomas B. Shea

  • Equity:
    Stock and stock options in Sevo Nutraceuticals, who markets the formulation used in this study, as Perceptiv
    Patents/Royalties
    My institution (UMass Lowell) and I receive royalties from the sale of Perceptiv by Sevo Nutraceuticals. I am the lead inventor of a US patent on this formulation.